Abstract submission has now closed and the review process has begun. Authors will be notified of the success of their submission on Friday, 16 October 2015.
Please read all information on this page and ensure you download the abstract submission word template below before submitting your abstract.
You are invited to submit an abstract/s to be reviewed for inclusion in the conference program as either an oral and/or poster presentation. Where a submission is not accepted for an oral presentation, the author will be offered a poster presentation that will be on display for the entirety of the meeting.
Oral presentations – 10 minutes duration with 5 minutes for questions
Poster presentations – posters will be on display for the duration of the conference, with authors in attendance at a specified day/time
Closing date for abstract submission is Friday, 11 September 2015. Authors will be notified of the success of their submission on Friday, 16 October 2015.
Abstracts will be considered for the following prize categories:
- APSA Pharmacy Practice Prize (APSA student oral communication prize)
- APSA Pharmaceutical Sciences Prize (APSA student oral communication prize)
- APSA Pharmacy Education (APSA student oral communication prize)
- APSA Pharmacy Practice Prize (APSA student poster prize)
- APSA Pharmaceutical Sciences Prize (APSA student poster prize)
- APSA Pharmacy Education (APSA student poster prize)
- ASCEPT Garth McQueen Prize (ASCEPT student oral communication prize)
- ASCEPT Clinical Pharmacology Trainee Prize (oral communication prize)
- ASCEPT Gillian Shenfield Early Educator Award
- ASCEPT Neville Percy Prize (Higher Degree student poster prize)
- ASCEPT Robert Whelan Prize (Honours student poster prize)
- ASCEPT Integrative Pharmacology/Toxicology Prize (Honours or Higher Degree student poster)
- ASCEPT Special Interest Group Poster Prizes (Students whose research falls under an area of interest of one of ASCEPTs Special Interest Groups)
Abstracts are invited for submission in the following themes:
|• Cardiovascular||• Clinical Pharmacology|
|• Clinical Pharmacology Trainee||• Drug Discovery|
|• Drug Disposition and Response||• Education|
|• Inflammation/respiratory||• Neuro- and Behavioural Pharmacology|
|• Pharmacogenomics||• Pharmacoepidemiology|
|• Toxicology||• Urogenital and Gastrointestinal|
|• Pharmacy Practice||• Pharmaceutical Science|
Successful authors are required to register and pay the appropriate registration fees for the conference, in order to ensure their abstract is included in the final program.
Instructions to Authors
Before proceeding to submit your abstract, please read the following author instructions to ensure you have all of the information that will be needed to complete the submission process. Please pay particular attention to these instructions as abstracts that do not conform will not be accepted by the editors.
Abstracts MUST be typed into the following Word template:
- Abstracts must be submitted via the online abstract submission site.
- Abstracts must be submitted on the word template.
- Do not change the page margins or any set up features.
- The abstract must fit within the space on the template provided. This includes a figure or table, title, authors and any references.
- The abstract must be one page only (using the preset margins this is actually half an A4 page).
- The abstract should be typed in 10 point Times New Roman font (do not use “bold” type)
- All text, including the heading, should be entered in sentence case (do not type in CAPITAL LETTERS)
- If inserting colour tables and images into the template, please keep in mind that these may not reproduce well on a monotone printer, so it is preferable that the images used be suitable for black and white printing.
1. Requirements for preparation of abstracts
Abstracts submitted for scientific sessions should describe work that has not been published or presented at another national meeting. The selection of contributions for scientific sessions will depend on the quality of the abstract submitted.
2. Title box
Use sentence case, bold, Times Roman font 10 point, 200 character limit (including spaces). Concisely encapsulate the work presented in the abstract. Sentence case is when you only capitalise the first letter of the first word in a heading – like you would in a sentence. Proper nouns also have a capital.
Starting on a new line, without a line-space to the Title, list the Presenting Author first, followed by other authors and contact details entered as directed in the template. Use a mixture of upper and lower case text, e.g., Geoffrey A Harrison, Peter L McCartney & James H Lennon. Do not use ‘bold’ or ‘underline’.
Follow the authors’ address details immediately after the names (ie., do not start a new line). Author’s department and institution should be abbreviated. Superscript numbers should be used to link the author(s) to their address(es) presented (e.g. Geoffrey A Harrison1, Peter L McCartney1,2. Dept of Pharmacol, Univ of Melbourne1, Parkville, VIC; Dept of Clin Pharmacol, Royal Melbourne Hosp2, Parkville, VIC).
Leave one line space after the Authors/addresses. Do not indent. Type as one block of text and include sub-headings: Introduction, Aims, Methods, Results and Discussion (including any conclusions drawn from results). Start each heading on a new line with text immediately following heading and without additional line spacing. If any references are added, include one additional line spacing following the abstract text (see sample of references below). The abstract should be left-and right-justified. The text should be as informative as possible. Statements such as “The results will be discussed” are not acceptable and will likely result in rejection.
Concentration – use either molar or mass units as most appropriate: nmol/L, μmol/L, mmol/L, etc.; or: ng/L, µg/L, mg/L, etc.
Dose – use mg/kg, or mmol/kg, etc.
Dose schedules – use mg/kg per day, or mmol/kg per day etc.
Pressure – may be in mmHg, psi, Pascal, or Torr, etc, as appropriate.
Tension – may be in “g”, etc.
If an anaesthetic is used, it must be named along with the dose and route of administration.
8. Figures and tables
One figure or table is allowed per abstract; these should not contain a title or legend, and the table should not contain any vertical lines. PARTICULAR EMPHASIS SHOULD BE PLACED ON CLARITY AND ABSTRACT FORMAT. ANY ERRORS IN THE ABSTRACT MAY LEAD TO REJECTION. Abstracts will be printed in black and white only, therefore it is preferrable that you use greyscale images.
Use the format: mean±SEM (n= ; P<) e.g. 57±3 (n = 7, P<0.02).
If ± is used to indicate anything other than a standard error, e.g., a range or standard deviation, this should be specified in the abstract. Where appropriate, authors should ensure consistency in the number of decimal places used.
In the text, citations should appear as first author plus et al (if multiple authors) followed by year (eg., Medic et al, 2010). The listed references after the text of the abstract are to be shown in alphabetical order of first author. They should include authors’ last names followed by initials (use “et al” for three or more authors), year of publication (in brackets), the title of the journal (abbreviated in accordance with Index Medicus), volume number, and the first and last page numbers. References to articles in books should consist of the names of authors, year of publication, title of the book, the editors, page numbers, place of publication and the publishers. Example: Jagger MS et al (2010) Br J Clin Pharmacol 33:56-61.
11. Standard abbreviations
Excessive use of abbreviations should be avoided. All abbreviations should be defined when they are first used, except for the following standard abbreviations:
G-aminobutyric acid GABA
Area under curve AUC
Blood Pressure BP
Bovine serum albumin BSA
Cardiovascular system CVS
Central nervous system CNS
Confidence interval CI
Correlation coefficient r
Degrees of freedom d.f.
Deoxyribonucleic acid DNA
Diameter, inside i.d.
Diameter outside o.d.
Enzyme linked immunosorbent assay ELISA
Gas chromatography-mass spectroscopy GCMS
Gas-liquid chromatography GLC
Glomerular filtration rate GFR
Half life t1/2
High performance liquid chromatography HPLC
Inhibitory constant Ki
International unit iu
Liquid chromatography-mass spectrometry LC-MS
Mass Spectrometry MS
Michaelis constant Km
Molar concentration M
Optical rotation (+)(-)
Radiolabel (e.g. tritium) [3H]
Standard Deviation SD
Standard Error of the Mean SEM
Single Nucleotide Polymorphism SNP
Tandem mass spectrometry MSMS
Volume of Distribution VAPSA-ASCEPT_Abstract_Submission_Template